It has had strong momentum since November, but there is still plenty of upside left.

New CEO of Dexcom, Jake Leach, joined MobiHealthNews at the JPM Healthcare Conference to discuss his leadership priorities, ...

Dexcom reported preliminary, unaudited total revenue of $1.260 billion for the fourth quarter of 2025, an increase of 13% over the fourth quarter of 2024.

DexCom stock snapshot and recent performance DexCom (DXCM) has been drawing attention after recent price moves, with the ...

In his inaugural J.P. Morgan Healthcare Conference speech, newly minted Dexcom CEO Jake Leach looked to ease concerns over ...

DexCom, Inc. DXCM is well positioned for growth in the coming quarters, supported by the significant potential of the ...

Dexcom achieved FY25 revenues of around $4.66bn, corresponding to a 16% uplift over FY24.

While still a couple of years out, MD+DI gained some insights into Dexcom's next-generation sensor from an interview with the ...

Dexcom convinced a federal judge that its phrasing about market share in two statements about sales growth for certain ...

Apple Watch now supports glucose monitoring via CGMs like Dexcom G7, while Apple continues long-term work on non-invasive ...

DexCom, Inc. (Nasdaq:DXCM), the global leader in glucose biosensing, is ushering in the next era of transformative, ...